Skip to main content
TipRanks
Go Ultimate75% OFF

Enliven Therapeutics (ELVN) Balance Sheet

355 Followers

Enliven Therapeutics Balance Sheet

Enliven Therapeutics's total assets for Q3 2026 were $897.23M, a decrease of 1.43% from the previous quarter. ELVN total liabilities were $20.28M for the fiscal quarter, a 34.52% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 476.17M$ 325.76M$ 271.87M$ 83.30M$ 113.33M
$ 16.57M$ 15.91M$ 25.96M$ 160.12M$ 6.47M
$ 459.60M$ 309.85M$ 245.91M$ -76.83M$ 106.86M

Currency in USD

Enliven Therapeutics Liabilities to Assets

0200M400M600M0 %80 %160 %240 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets